Insulin Degludec (U-100) Vials and Ogivri Injection
Determining the interaction of Insulin Degludec (U-100) Vials and Ogivri Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: trastuzumab
Brand name: Herceptin, Kanjinti, Ogivri
Synonyms: Ogivri
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Degludec (U-100) Vials-Ogivri Intravenous
- Insulin Degludec (U-100) Vials-Ohm Allergy Relief
- Insulin Degludec (U-100) Vials-Olanzapine
- Insulin Degludec (U-100) Vials-Olanzapine and Fluoxetine
- Insulin Degludec (U-100) Vials-Olanzapine and Fluoxetine Capsules
- Insulin Degludec (U-100) Vials-Olanzapine Extended-Release Injection
- Ogivri Injection-Insulin Degludec (U-200) Prefilled Pens
- Ogivri Injection-Insulin degludec and liraglutide
- Ogivri Injection-Insulin degludec and liraglutide Subcutaneous
- Ogivri Injection-Insulin degludec Subcutaneous
- Ogivri Injection-Insulin detemir
- Ogivri Injection-Insulin Detemir (Cartridges and Prefilled Syringes)